Yobisin Tablet
NDC Package 72988-0012-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Yobisin (rehmannia root, angelica gigas root) tablets is adults: 3~6 tablets twice a day7 to 14 years old: 2-3 tablets twice a day. This formulation utilizes a tablet delivery system. Marketed by Lydia Co., Ltd., this product is identified by NDC 72988-0012.

Identification & Billing

NDC Package Code
72988-0012-1
Package Description
20 TABLET in 1 PACKAGE
Product Code
72988-0012
11-Digit Billing Format
72988001201

Clinical Specifications

Proprietary Name
Yobisin
Non-Proprietary Name
Rehmannia Root, Angelica Gigas Root
Substance Name
Akebia Stem; Alisma Plantago-aquatica Root; Angelica Gigas Root; Chinese Cinnamon; Forsythia Suspensa Fruit; Ginger; Licorice; Plantago Seed; Rehmannia Glutinosa Root; Rhubarb; Scutellaria Baicalensis Root
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults: 3~6 tablets twice a day7 to 14 years old: 2-3 tablets twice a day

Regulatory & Marketing

Labeler Name
Lydia Co., Ltd.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
04-22-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72988-0012-1 identifies a specific commercial package of 20 tablet in 1 package of Yobisin, a human over the counter drug labeled by Lydia Co., Ltd.. This tablet is formulated for oral use and contains akebia stem; alisma plantago-aquatica root; angelica gigas root; chinese cinnamon; forsythia suspensa fruit; ginger; licorice; plantago seed; rehmannia glutinosa root; rhubarb; scutellaria baicalensis root as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lydia Co., Ltd. on April 22, 2019. The current certification is valid through December 31, 2026.

How is this Lydia Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72988001201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
72988-0012-1
11-Digit CMS (5-4-2)
72988-0012-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.